Knowledge integration in cancer: Current landscape and future prospects

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 1, 2013, Pages 3-10

  Ioannidis, John P A ^a,b,c   Schully, Sheri D ^a   Lam, Tram Kim ^a   Khoury, Muin J ^a,d  

^a Knowledge Integration Team   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CLINICAL PRACTICE; EPIGENETICS; GENETIC ASSOCIATION; GENOTYPE; HEALTH CARE POLICY; HUMAN; INTEGRATION; KNOWLEDGE; MEDICAL INFORMATION; MEDICAL RESEARCH; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY; SYSTEMATIC REVIEW (TOPIC);

BIOMEDICAL RESEARCH; FEMALE; FORECASTING; HUMANS; KNOWLEDGE MANAGEMENT; MALE; MEDICAL INFORMATICS; NEOPLASMS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84872157935     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-1144     Document Type: Article

References (60)

1. Khoury MJ, Gwinn M, Dotson WD, Schully SD. Knowledge integration at the center of genomic medicine. Genet Med 2012;14:643-7.
2. Philippi S. Data and knowledge integration in the life sciences. Brief Bioinform 2008;9:451.
3. Best A, Terpstra JL, Moor G, Riley B, Norman CD, Glasgow RE. Building knowledge integration systems for evidence-informed decisions. J Health Organ Manag 2009;23:627-41.
4. Ioannidis JP. The importance of potential studies that have not existed and registration of observational data sets. JAMA 2012;308:575-6.
5. Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124.
6. Kheifets L, Olsen J. Should epidemiologists always publish their results? Yes, almost always. Epidemiology 2008;19:532-3.
7. Ioannidis JP. Journals should publish all "null" results and should sparingly publish "positive" results. Cancer Epidemiol Biomarkers Prev 2006;15:186.
8. Dwan K, Altman DG, Cresswell L, Blundell M, Gamble CL, Williamson PR. Comparison of protocols and registry entries to published reports for randomised controlled trials. Cochrane Database Syst Rev 2011;19:MR000031.
9. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010;340:c365.
10. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 2008;3:e3081.
11. Kavvoura FK, Liberopoulos G, Ioannidis JP. Selection in reported epidemiological risks: an empirical assessment. PLoS Med 2007;4:e79.
12. Lash TL, Vandenbroucke JP. Should preregistration of epidemiologic study protocols become compulsory? Reflections and a counterproposal. Epidemiology 2012;23:184-8.
13. National Center for Biotechnology Information, National Library of Medicine. [cited 2012 Sep 6]; Available from: http://www.ncbi.nlm.nih.gov./.
14. Alsheikh-Ali AA, Qureshi W, Al-Mallah MH, Ioannidis JP. Public availability of published research data in high-impact journals. PLoS One 2011;6:e24357.
15. Savage CJ, Vickers AJ. Empirical study of data sharing by authors publishing in PLoS journals. PLoS One 2009;4:e7078.
16. RRResearch. Available from: http://rrresearch.fieldofscience.com/2010/12/ arsenic-associated-bacteria-nasas.html. Last accessed October 1, 2012.
17. Khoury MJ, Bertram L, Boffetta P, Butterworth AS, Chanock SJ, Dolan SM, et al. Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol 2009;170:269-79.
18. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007;39:17-23.
19. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008;40:827-34.
20. Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet 2012;8:e1002548.
21. Ioannidis JP, Rosenberg PS, Goedert JJ, O'Brien TR International Meta-analysis of HIV Host Genetics. Commentary: meta-analysis of individual participants' data in genetic epidemiology. Am J Epidemiol 2002;156:204-10.
22. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999;28:1-9.
23. Zeggini E, Ioannidis JP. Meta-analysis in genome-wide association studies. Pharmacogenomics 2009;10:191-201.
24. G €ogele M, Minelli C, Thakkinstian A, Yurkiewich A, Pattaro C, Pramstaller PP, et al. Methods for meta-analyses of genome-wide association studies: critical assessment of empirical evidence. Am J Epidemiol 2012;175:739-49.
25. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genomewide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009;106:9362-7.
26. Province MA, Hadley EC, Hornbrook MC, Lipsitz LA, Miller JP, Mulrow CD,et al. Theeffects of exercise on falls in elderly patients.Apreplanned meta-analysis of the FICSIT Trials. Frailty and injuries: cooperative studies of intervention techniques. JAMA 1995;273:1341-7.
27. Manolio TA, Weis BK, Cowie CC, Hoover RN, Hudson K, Kramer BS, et al. New models for large prospective studies: is there a better way? Am J Epidemiol 2012;175:859-66.
28. Fortier I, Burton PR, Robson PJ, Ferretti V, Little J, L'Heureux F, et al. Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol 2010;39:1383-93.
29. Macleod M. Why animal research needs to improve. Nature 2011;477:511.
30. Sena ES, van der Worp HB, Bath PM, Howells DW, Macleod MR. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 2010;8:e1000344.
31. Seminara D, Khoury MJ, O'Brien TR, Manolio T, Gwinn ML, Little J, et al. The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology 2007;18:1-8.
32. Zhang LQ, Zhou JN, Wang J, Liang GD, Li JY, Zhu YD, et al. Absence of association between N-acetyltransferase 2 acetylator status and colorectal cancer susceptibility: based on evidence from 40 studies. PLoS One 2012;7:e32425.
33. Siontis KC, Patsopoulos NA, Ioannidis JP. Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies. Eur J Hum Genet 2010;18:832-7.
34. Ioannidis JP, Tarone R, McLaughlin JK. The false-positive to false-negative ratio in epidemiologic studies. Epidemiology 2011;22:450-6.
35. Pan Z, Trikalinos TA, Kavvoura FK, Lau J, Ioannidis JP. Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature. PLoS Med 2005;2:e334.
36. Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials 1998;19:159-66.
37. Ioannidis JP. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ 2009;181:488-93.
38. International Agency for Research on Cancer. Preamble to the IARC Monographs (amended January 2006). Lyon, France: International Agency for Research on Cancer; 2009.
39. Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, Vineis P, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 2008;37:120-32.
40. Boffetta P, Winn DM, Ioannidis JP, Thomas DC, Little J, Smith GD, et al. Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans. Int J Epidemiol 2012;41:686-704.
41. Agency for Healthcare Research and Quality. US Preventive Services Task Force. [cited 2012 Sep 1]; Available from: http://www.ahrq.gov/clinic/uspstfix. htm.
42. The guide to community preventive services. [cited 2012 Sep 1]; Available from: http://www.thecommunityguide.org/index.html.
43. Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, van Ballegooijen M, Zauber AG, Jemal A. Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev 2012;21:728-36.
44. Kyzas PA, Loizou KT, Ioannidis JP. Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst 2005;97:1043-55.
45. Kyzas PA, Denaxa-Kyza D, Ioannidis JP. Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect. J Natl Cancer Inst 2007;99:236-43.
46. Kyzas PA, Denaxa-Kyza D, Ioannidis JP. Almost all articles on cancer prognostic markers report statistically significant results. Eur J Cancer 2007;43:2559-79.
47. Schoenfeld J, Ioannidis JPA. Is everything we eat associated with cancer? A systematic cookbook review. Am J Clin Nutr. 2012 Nov 28. [Epub ahead of print].
48. Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. PLoS Med 2012;9:e1001216.
49. Mallett S, Royston P, Waters R, Dutton S, Altman DG. Reporting performance of prognostic models in cancer: a review. BMC Med 2010;8:21.
50. Mallett S, Timmer A, Sauerbrei W, Altman DG. Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines. Br J Cancer 2010;102:173-80.
51. Baggerly KA, Coombes KR. Deriving chemosensitivity from cell lines: forensic bioinformatics and reproducible research in high-throughput biology. Ann Appl Stat 2009;3:1309-34.
52. Begley CG, Ellis LM. Drug development: raise standards for preclinical cancer research. Nature 2012;483:531-3.
53. Glasgow RE, Vinson C, Chambers D, Khoury MJ, Kaplan RM, Hunter C. National Institutes of Health approaches to dissemination and implementation science: current and future directions. Am J Public Health 2012;102:1274-81.
54. Deverka PA, Schully SD, Ishibe N, Carlson JJ, Freedman A, Goddard KA, et al. Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies. Genet Med 2012;14:656-62.
55. Lenfant C. Shattuck lecture-clinical research to clinical practice-lost in translation? N Engl J Med 2003;349:868-74.
56. Andre F, McShane LM, Michiels S, Ransohoff DF, Altman DG, Reis-Filho JS, et al. Biomarker studies: a call for a comprehensive biomarker study registry. Nat Rev Clin Oncol 2011;8:171-6.
57. Donoho DL, Maleki A, Rahman IU, Shahram M, Stodden V. Reproducible research in computational harmonic analysis. Comput Sci Eng 2009;11:8-18.
58. Baggerly K. Disclose all data in publications. Nature 2010;467:401.
59. Ioannidis JP, Khoury MJ. Improving validation practices in "omics" research. Science 2011;334:1230-2.
60. The Reproducibility Initiative. [cited 2012 Sep 1]; Available from: https://www.scienceexchange.com/reproducibility.